DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Dr. Mark Pykett, President and CEO, will participate at the Credit Suisse 2012 Healthcare Conference from November 14-16, 2012 at the Arizona Biltmore Hotel in Phoenix, Arizona. Dr. Pykett will provide an update of the Company and its development programs on Wednesday, November 14, 2012 at 7:30 AM Mountain Time (9:30 AM ET).
